Evaluation of the BD MAX™ Vaginal Panel for the detection of vaginal infections in a sexual health service in the UK.

Authors:
Jackie Sherrard
Jackie Sherrard
Churchill Hospital
United Kingdom

Int J STD AIDS 2019 Mar 8;30(4):411-414. Epub 2019 Jan 8.

Department of Sexual Health, Buckinghamshire Healthcare NHS Trust, Wycombe General Hospital, Wycombe, UK.

The aim of this study is to compare the performance of the BD MAX™ Vaginal Panel (Becton, Dickinson and company, Franklin Lakes, NJ, USA) in the diagnosis of bacterial vaginosis (BV), candidiasis and trichomoniasis with current standard tests in a UK specialist sexual health service. Women with abnormal vaginal discharge attending the service who had not used douches or vaginal treatment in the preceding 48 hours had two vulvovaginal swabs taken: one for Chlamydia and gonorrhoea nucleic acid amplification test (NAAT) and one for testing on the BD MAX™ Vaginal Panel on the BD MAX System. Speculum examination was then performed and vaginal swabs taken for vaginal pH, and microscopy of vaginal secretions: Gram stain for Candida and BV using the Hay-Ison score and wet-mount for clue cells and Trichomonas vaginalis (TV). Forty-six (23.6%) women were negative for all three infections on the Vaginal Panel. Ninety-three were positive for BV (47.7%), 70 (35.9%) for Candida and 9 (4.6%) had TV detected. Thirty-six women tested positive for both BV and Candida on the BD MAX™. The investigational test sensitivity for all Candida species was 86.4% with a specificity of 86.0% and for BV the sensitivity was 94.4% with a specificity of 79%. The sensitivity for BV was good but specificity is lower than previously described and may reflect the high rates of sexually transmitted infections in this population which potentially altered the vaginal microbiome. The lower specificity and sensitivity for Candida is not unexpected as a high proportion of women are colonised with Candida, and in all cases other pathogens were found to account for their symptoms. NAATs do not provide the immediate results available from in-clinic microscopy but were easy to perform and process and offer benefits over the traditional "high vaginal swab" performed in primary care and other settings where immediate microscopy is unavailable.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0956462418815284DOI Listing
March 2019
3 Reads

Publication Analysis

Top Keywords

vaginal panel
16
max™ vaginal
12
vaginal
12
sensitivity candida
8
health service
8
sexual health
8
candida
6
detected thirty-six
4
thirty-six women
4
women tested
4
tested positive
4
46% detected
4
candida 46%
4
ninety-three positive
4
positive 477%
4
477% 359%
4
359% candida
4
positive candida
4
max™ investigational
4
specificity 860%
4

References

(Supplied by CrossRef)
Article in Sex Transm Infect
Ison CA et al.
Sex Transm Infect 2002
Article in Am J Med
Amsel R et al.
Am J Med 1983
Article in Obstet Gynecol
Gaydos CA et al.
Obstet Gynecol 2017
Article in IUSTI World and European Congress
Van Der Pol B et al.
IUSTI World and European Congress 2018
Article in Sex Transm Infect
Van Der Pol B et al.
Sex Transm Infect 2017

Similar Publications